中国药科大学学报2017，Vol.48Issue(6)：745-750,6.DOI:10.11665/j.issn.1000-5048.20170618
中日创新药物市场准入政策环境比较及对我国的启示
Comparison of Sino-Japanese innovative drug market access policy environment and enlightenment to China
摘要
Abstract
This paper summarizes the current situation and existing problems of China's innovative drug market access policy from the basic aspects of innovative drug market access,such as intellectual property rights,drug pricing,medical insurance and bidding procurement.Based on the comprehensive analysis of Japan's innovative drug market access policy,through the comprehensive comparison of the two countries innovative drug market access policy differences,the paper put forward the practical measures to encourage the listing of innovative drugs in China,from the intellectual property rights,drug pricing,medical security and tender procurement in four areas.关键词
创新药物/市场准入/政策比较/中国/日本Key words
innovative drugs/market access/policy comparison分类
管理科学引用本文复制引用
王恩楠,陈怡,褚淑贞..中日创新药物市场准入政策环境比较及对我国的启示[J].中国药科大学学报,2017,48(6):745-750,6.基金项目
国家社会科学基金资助项目(No.15ZDB167)This study was supported by the National Social Science Foundation of China (No.15ZDB617) （No.15ZDB167）
